Two Sigma Advisers’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-668,775
| Closed | -$26.5M | – | 2742 |
|
|
2024
Q1 | $26.5M | Buy |
668,775
+404,700
| +153% | +$11.9M | 0.06% | 285 |
|
|
2023
Q4 | $5.03M | Buy |
264,075
+18,000
| +7% | +$250K | 0.01% | 798 |
|
|
2023
Q3 | $2.82M | Buy |
246,075
+159,700
| +185% | +$1.97M | 0.01% | 1012 |
|
|
2023
Q2 | $888K | Buy |
86,375
+45,400
| +111% | +$409K | ﹤0.01% | 1582 |
|
|
2023
Q1 | $316K | Sell |
40,975
-24,200
| -37% | -$193K | ﹤0.01% | 2118 |
|
|
2022
Q4 | $479K | Sell |
65,175
-3,300
| -5% | -$21.1K | ﹤0.01% | 1895 |
|
|
2022
Q3 | $493K | Sell |
68,475
-33,100
| -33% | -$273K | ﹤0.01% | 1847 |
|
|
2022
Q2 | $864K | Sell |
101,575
-12,600
| -11% | -$109K | ﹤0.01% | 1672 |
|
|
2022
Q1 | $1.02M | Buy |
114,175
+6,400
| +6% | +$55.3K | ﹤0.01% | 1629 |
|
|
2021
Q4 | $1.49M | Buy |
107,775
+66,100
| +159% | +$819K | ﹤0.01% | 1335 |
|
|
2021
Q3 | $445K | Sell |
41,675
-27,500
| -40% | -$253K | ﹤0.01% | 1975 |
|
|
2021
Q2 | $623K | Sell |
69,175
-56,800
| -45% | -$617K | ﹤0.01% | 1845 |
|
|
2021
Q1 | $1.33M | Buy |
125,975
+23,200
| +23% | +$289K | ﹤0.01% | 1485 |
|
|
2020
Q4 | $1.29M | Buy |
102,775
+29,300
| +40% | +$288K | ﹤0.01% | 1454 |
|
|
2020
Q3 | $646K | Buy |
+73,475
| New | +$672K | ﹤0.01% | 1703 |
|
Two Sigma Advisers's ALPN Position: Q2 2024 in Review
Two Sigma Advisers sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 668,775 shares — an estimated $26.5M sold.
Two Sigma Advisers first reported a position in ALPN in Q3 2020 and held it in 15 quarters. The position peaked at $26.5M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Two Sigma Advisers reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Two Sigma Advisers sold 668,775 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $26.5M.
- Two Sigma Advisers first reported a position in Alpine Immune Sciences Inc in Q3 2020 and held it in 15 quarters.
- Two Sigma Advisers's Alpine Immune Sciences Inc position peaked at $26.5M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.